Under his leadership, the department has axed crucial funding that helps state and local governments promote vaccine awareness and ... One person infected with COVID-19 can spread it to roughly ...

This initiative will fund the National Institutes of Health's development of universal influenza and coronavirus vaccines, including candidates BPL-1357 and BPL-24910, which grant protection ...

Only one tenth of hospitalized adults aged 60 years or older received the respiratory syncytial virus (RSV) vaccine during its first season. Sociodemographic differences were observed, with higher ...

In recent weeks, the Trump administration has questioned the safety testing of coronavirus vaccines, injecting uncertainty over whether an updated shot would be available in the fall, when one is ...

Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access ... The importance of innovation The COVID-19 vaccines were brought to market faster than any other ...

During the COVID-19 pandemic, Prasad reached a much broader audience as a critic of mask mandates, lockdowns and moves to speed the availability of vaccine boosters from Pfizer and Moderna.

The COVID-19 pandemic, stumbles and all, gave health officials lessons in effective public health communication and outreach.

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As clinical trials advance, Ben Hargreaves finds the technology is poised to ...